Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
After finishing at $4.64 in the prior trading day, Karyopharm Therapeutics Inc (NASDAQ: KPTI) closed at $4.59, down -1.08%. In other words, the price has decreased by -$1.08 from its previous closing price. On the day, 64571.0 shares were traded. KPTI stock price reached its highest trading level at $4.74 during the session, while it also had its lowest trading level at $4.34.
Ratios:
Our goal is to gain a better understanding of KPTI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.28 and its Current Ratio is at 1.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on January 19, 2023, initiated with a Overweight rating and assigned the stock a target price of $8.
On November 04, 2022, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $7 to $10.
JP Morgan Upgraded its Underweight to Neutral on February 09, 2022, while the target price for the stock was maintained at $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 06 ’25 when Paulson Richard A. sold 236 shares for $7.12 per share. The transaction valued at 1,680 led to the insider holds 82,503 shares of the business.
Rangwala Reshma sold 419 shares of KPTI for $2,585 on Apr 23 ’25. The EVP & Chief Medical Officer now owns 28,853 shares after completing the transaction at $6.17 per share. On Apr 04 ’25, another insider, Paulson Richard A., who serves as the President and CEO of the company, sold 245 shares for $3.74 each. As a result, the insider received 916 and left with 82,739 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KPTI now has a Market Capitalization of 39657144 and an Enterprise Value of 229918160. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.28. Its current Enterprise Value per Revenue stands at 1.618 whereas that against EBITDA is -1.938.
Stock Price History:
The Beta on a monthly basis for KPTI is 0.29, which has changed by -0.6921529 over the last 52 weeks, in comparison to a change of 0.09362543 over the same period for the S&P500. Over the past 52 weeks, KPTI has reached a high of $17.40, while it has fallen to a 52-week low of $3.51. The 50-Day Moving Average of the stock is -13.45%, while the 200-Day Moving Average is calculated to be -52.29%.
Shares Statistics:
The stock has traded on average 132.65K shares per day over the past 3-months and 85120 shares per day over the last 10 days, according to various share statistics. A total of 8.57M shares are outstanding, with a floating share count of 7.96M. Insiders hold about 7.84% of the company’s shares, while institutions hold 50.13% stake in the company. Shares short for KPTI as of 1745971200 were 1978892 with a Short Ratio of 14.92, compared to 1743379200 on 1310201. Therefore, it implies a Short% of Shares Outstanding of 1978892 and a Short% of Float of 23.27.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
